Dr Mehrnoosh Karizi Badiee, OD,MD | |
617 Potomac Station Dr Ne Ste A, Leesburg, VA 20176-1817 | |
(703) 669-4646 | |
Not Available |
Full Name | Dr Mehrnoosh Karizi Badiee |
---|---|
Gender | Female |
Speciality | Optometry |
Experience | 12 Years |
Location | 617 Potomac Station Dr Ne Ste A, Leesburg, Virginia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205270170 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 0618002198 (Virginia) | Primary |
Provider Name | Leesburg Optometry, Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1740345750 PECOS PAC ID: 3476638404 Enrollment ID: O20080314000140 |
News Archive
It's the drumbeat you hear every year - time to roll up your sleeve for your annual flu vaccination. But, is it really worth the effort? Does the flu vaccine really work?
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with ALN-AT3, a subcutaneously administered RNAi therapeutic targeting antithrombin (AT) for the treatment of hemophilia and rare bleeding disorders (RBD), at the 55th Annual Meeting of the American Society of Hematology (ASH) held December 7 - 10, 2013 in New Orleans.
A daily dose of omega-3 fatty acids did not reduce the risk of cardiac events, including secondary heart attack, stroke, bypass surgery or death, among elderly people who had survived a recent heart attack, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.
GVK Biosciences (GVK BIO) today announced that it is extending its Clinical Biomarker Database (GOBIOM) license to the Biomarker Qualification Group of the US Food and Drug Administration (US FDA).
› Verified 6 days ago
Provider Name | Dulles Optometry Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1699956136 PECOS PAC ID: 6901083401 Enrollment ID: O20110609000817 |
News Archive
It's the drumbeat you hear every year - time to roll up your sleeve for your annual flu vaccination. But, is it really worth the effort? Does the flu vaccine really work?
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with ALN-AT3, a subcutaneously administered RNAi therapeutic targeting antithrombin (AT) for the treatment of hemophilia and rare bleeding disorders (RBD), at the 55th Annual Meeting of the American Society of Hematology (ASH) held December 7 - 10, 2013 in New Orleans.
A daily dose of omega-3 fatty acids did not reduce the risk of cardiac events, including secondary heart attack, stroke, bypass surgery or death, among elderly people who had survived a recent heart attack, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.
GVK Biosciences (GVK BIO) today announced that it is extending its Clinical Biomarker Database (GOBIOM) license to the Biomarker Qualification Group of the US Food and Drug Administration (US FDA).
› Verified 6 days ago
Provider Name | Winchester Optometry Pllc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1649417387 PECOS PAC ID: 6901045384 Enrollment ID: O20130614000354 |
News Archive
It's the drumbeat you hear every year - time to roll up your sleeve for your annual flu vaccination. But, is it really worth the effort? Does the flu vaccine really work?
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with ALN-AT3, a subcutaneously administered RNAi therapeutic targeting antithrombin (AT) for the treatment of hemophilia and rare bleeding disorders (RBD), at the 55th Annual Meeting of the American Society of Hematology (ASH) held December 7 - 10, 2013 in New Orleans.
A daily dose of omega-3 fatty acids did not reduce the risk of cardiac events, including secondary heart attack, stroke, bypass surgery or death, among elderly people who had survived a recent heart attack, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.
GVK Biosciences (GVK BIO) today announced that it is extending its Clinical Biomarker Database (GOBIOM) license to the Biomarker Qualification Group of the US Food and Drug Administration (US FDA).
› Verified 6 days ago
Provider Name | Myeyedr Optometry Of Virginia, Pllc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1174933691 PECOS PAC ID: 0143448456 Enrollment ID: O20140828001354 |
News Archive
It's the drumbeat you hear every year - time to roll up your sleeve for your annual flu vaccination. But, is it really worth the effort? Does the flu vaccine really work?
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with ALN-AT3, a subcutaneously administered RNAi therapeutic targeting antithrombin (AT) for the treatment of hemophilia and rare bleeding disorders (RBD), at the 55th Annual Meeting of the American Society of Hematology (ASH) held December 7 - 10, 2013 in New Orleans.
A daily dose of omega-3 fatty acids did not reduce the risk of cardiac events, including secondary heart attack, stroke, bypass surgery or death, among elderly people who had survived a recent heart attack, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.
GVK Biosciences (GVK BIO) today announced that it is extending its Clinical Biomarker Database (GOBIOM) license to the Biomarker Qualification Group of the US Food and Drug Administration (US FDA).
› Verified 6 days ago
Provider Name | New Era Eyecare Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1801108576 PECOS PAC ID: 3577696657 Enrollment ID: O20150213001739 |
News Archive
It's the drumbeat you hear every year - time to roll up your sleeve for your annual flu vaccination. But, is it really worth the effort? Does the flu vaccine really work?
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with ALN-AT3, a subcutaneously administered RNAi therapeutic targeting antithrombin (AT) for the treatment of hemophilia and rare bleeding disorders (RBD), at the 55th Annual Meeting of the American Society of Hematology (ASH) held December 7 - 10, 2013 in New Orleans.
A daily dose of omega-3 fatty acids did not reduce the risk of cardiac events, including secondary heart attack, stroke, bypass surgery or death, among elderly people who had survived a recent heart attack, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.
GVK Biosciences (GVK BIO) today announced that it is extending its Clinical Biomarker Database (GOBIOM) license to the Biomarker Qualification Group of the US Food and Drug Administration (US FDA).
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Mehrnoosh Karizi Badiee, OD,MD 8614 Westwood Center Dr Fl 9, Vienna, VA 22182-2442 Ph: (703) 847-8899 | Dr Mehrnoosh Karizi Badiee, OD,MD 617 Potomac Station Dr Ne Ste A, Leesburg, VA 20176-1817 Ph: (703) 669-4646 |
News Archive
It's the drumbeat you hear every year - time to roll up your sleeve for your annual flu vaccination. But, is it really worth the effort? Does the flu vaccine really work?
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with ALN-AT3, a subcutaneously administered RNAi therapeutic targeting antithrombin (AT) for the treatment of hemophilia and rare bleeding disorders (RBD), at the 55th Annual Meeting of the American Society of Hematology (ASH) held December 7 - 10, 2013 in New Orleans.
A daily dose of omega-3 fatty acids did not reduce the risk of cardiac events, including secondary heart attack, stroke, bypass surgery or death, among elderly people who had survived a recent heart attack, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.
GVK Biosciences (GVK BIO) today announced that it is extending its Clinical Biomarker Database (GOBIOM) license to the Biomarker Qualification Group of the US Food and Drug Administration (US FDA).
› Verified 6 days ago
Dr. Yu-ting Julie Chung, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 19360 Compass Creek Pkwy, Leesburg, VA 20175 Phone: 571-258-4644 Fax: 571-248-4643 | |
Dr. Marsha C Gage, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1200 Edwards Ferry Rd Ne, Leesburg, VA 20176 Phone: 709-946-0517 | |
Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1047 Edwards Ferry Rd Ne, Leesburg, VA 20176 Phone: 703-737-7798 Fax: 703-737-7889 | |
Dr. Tina Douroudian, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1047 Edwards Ferry Rd Ne, Leesburg, VA 20176 Phone: 703-737-7798 Fax: 703-737-7889 | |
Dr. Lucy S Lee, O.D Optometrist Medicare: Not Enrolled in Medicare Practice Location: 19369 Promenade Drive, K102, Leesburg, VA 20176 Phone: 703-424-8690 | |
Dr. Donald F. Gabriel, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 231 Wirt St Nw, Leesburg, VA 20176 Phone: 703-953-8198 |